In 2021, USP32 was found to be overexpressed in epithelial ovarian cancer (EOC), particularly in metastatic peritoneal tumors, and it positively regulates the proliferation and epithelial-mesenchymal transition (EMT) capabilities of cancer cells [9]. Here, USP32 is linked to cancer.